Insulet Gets FDA Clearance for Omnipod 5 Automated Insulin Delivery System

Insulet (PODD) announced Friday that it has received FDA clearance for its Omnipod 5 Automated Insulin Delivery System for people aged six years and older who have type 1 diabetes.

Omnipod 5 is the first tubeless automated insulin delivery system that integrates with the Dexcom (DXCM) G6 Continuous Glucose Monitoring System and a smartphone to automatically adjust insulin levels.

Omnipod 5 is designed to make ...